VBLT - 1.84 Pre-market at 1.99/2.00 VBL Therapeutics Highlights Publication Of Results From Interim Analysis of OVAL Phase 3 Registration Enabling Study Of VB-111 In Ovarian Cancer https://stockcharts.com/h-sc/ui?s=vblt